We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 9,067 results
  1. Late/delayed gadolinium enhancement in MRI after intravenous administration of extracellular gadolinium-based contrast agents: is it worth waiting?

    The acquisition of images minutes or even hours after intravenous extracellular gadolinium-based contrast agents (GBCA) administration (“Late/Delayed...

    Marco Parillo, Carlo Augusto Mallio, ... Carlo Cosimo Quattrocchi in Magnetic Resonance Materials in Physics, Biology and Medicine
    Article 22 February 2024
  2. Review of strategies to reduce the contamination of the water environment by gadolinium-based contrast agents

    Gadolinium-based contrast agents (GBCA) are essential for diagnostic MRI examinations. GBCA are only used in small quantities on a per-patient basis;...

    Helena M. Dekker, Gerard J. Stroomberg, ... Mathias Prokop in Insights into Imaging
    Article Open access 27 February 2024
  3. The role of gadolinium-based contrast agents in magnetic resonance imaging structured reporting and data systems (RADS)

    Among the 28 reporting and data systems (RADS) available in the literature, we identified 15 RADS that can be used in Magnetic Resonance Imaging...

    Marco Parillo, Carlo Augusto Mallio, ... Carlo Cosimo Quattrocchi in Magnetic Resonance Materials in Physics, Biology and Medicine
    Article Open access 13 September 2023
  4. Comparison of the Pharmacokinetics of Gadolinium-Based and Iron Oxide-Based Contrast Agents inside the Lymphatic Structure using Magnetic Resonance Lymphangiography

    Purpose

    Gadolinium (Gd)-based contrast agents are primarily used for contrast-enhanced magnetic resonance lymphangiography (MRL). However, overcoming...

    Yeon Ji Chae, Kyung Won Kim, ... Dong-Cheol Woo in Molecular Imaging and Biology
    Article 29 April 2024
  5. Impact of gadolinium-based contrast agents on attenuation correction and tracer quantification in neuroendocrine malignancies in [68Ga]-DOTATOC PET/MRI

    Objectives

    To investigate the influence of Gadolinium-based contrast agents (CA) on MR-based attenuation correction (MRAC) in evaluating target...

    Aleksandar Milosevic, Michal Chodyla, ... Benedikt M. Schaarschmidt in Clinical and Translational Imaging
    Article 25 April 2024
  6. Use of gadolinium-based contrast agents in multiple sclerosis: a review by the ESMRMB-GREC and ESNR Multiple Sclerosis Working Group

    Abstract 

    Magnetic resonance imaging (MRI) is the most sensitive technique for detecting inflammatory demyelinating lesions in multiple sclerosis (MS)...

    Àlex Rovira, Fabio M. Doniselli, ... Carlo C. Quattrocchi in European Radiology
    Article 02 September 2023
  7. Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study

    Background

    We compared T1- and T2-weighted signal intensities of liver-specific (gadoxetate, gadobenate) and non-specific (gadoterate) gadolinium...

    Johannes M. Froehlich, Leen Moussa, ... Simon Matoori in European Radiology Experimental
    Article Open access 24 April 2023
  8. Spectral computed tomography angiography using a gadolinium-based contrast agent for imaging of pathologies of the aorta

    Objectives

    Especially patients with aortic aneurysms and multiple computed tomography angiographies (CTA) might show medical conditions which oppose...

    Markus Graf, Felix G. Gassert, ... Jonathan Nadjiri in The International Journal of Cardiovascular Imaging
    Article Open access 29 February 2024
  9. Safe and optimized use of gadolinium-based contrast agents in neuroimaging

    Àlex Rovira, Carlo C. Quattrocchi in European Radiology
    Article 25 November 2023
  10. Ultrasmall iron oxide nanoparticles and gadolinium-based contrast agents in magnetic resonance imaging: a systematic review and meta-analysis

    Background

    A comparison between the ultra-small iron oxide nanoparticles (US-IO) and commercial gadolinium-based contrast agents (Dotarem) as positive...

    Azadeh Amraee, Samideh Khoei, ... Ayuob Aghanejad in Clinical and Translational Imaging
    Article 15 October 2022
  11. Added value of gadolinium-based contrast agents for magnetic resonance evaluation of adnexal torsion in girls

    Purpose

    Ultrasound is the first-line imaging modality to evaluate adnexa in girls with clinical suspicion of torsion. Patients with equivocal...

    Mohamed M. Elsingergy, Edward R. Oliver, ... Susan J. Back in Abdominal Radiology
    Article 17 August 2022
  12. The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis

    Objective

    To determine whether reliable brain atrophy measures can be obtained from post-contrast 3D T1-weighted images in patients with multiple...

    Ingrid Anne Lie, Emma Kerklingh, ... Hugo Vrenken in European Radiology
    Article Open access 03 January 2022
  13. Evaluation of glymphatic-meningeal lymphatic system with intravenous gadolinium-based contrast-enhancement in cerebral small-vessel disease

    Objective

    To investigate the feasibility of using noninvasive neuroimaging methods in visualizing and evaluating the clearance of the...

    Miaoyi Zhang, Jie Tang, ... Jianhui Fu in European Radiology
    Article 06 July 2023
  14. Gadolinium retention within multiple rat organs after intra-articular administration of gadolinium-based contrast agents

    Objective

    To characterize the extent of retention and biodistribution of gadolinium (Gd) following intra-articular (IA) injection of linear and...

    Michael D. Ringler, Nicholas G. Rhodes, ... Jennifer S. McDonald in Skeletal Radiology
    Article Open access 06 January 2021
  15. Waiting times between examinations with intravascularly administered contrast media: a review of contrast media pharmacokinetics and updated ESUR Contrast Media Safety Committee guidelines

    Abstract

    The pharmacokinetics of contrast media (CM) will determine how long safe waiting intervals between successive CT or MRI examinations should...

    Aart J. van der Molen, Ilona A. Dekkers, ... Olivier Clement in European Radiology
    Article Open access 12 October 2023
  16. Gadolinium contrast agents: dermal deposits and potential effects on epidermal small nerve fibers

    Small fiber neuropathy (SFN) affects unmyelinated and thinly myelinated nerve fibers causing neuropathic pain with distal distribution and autonomic...

    Heidrun H. Krämer, Patrick Bücker, ... Christoph van Thriel in Journal of Neurology
    Article Open access 04 May 2023
  17. Gold nanoparticles conjugated with epidermal growth factor and gadolinium for precision delivery of contrast agents in magnetic resonance imaging

    The utilization of contrast agents in magnetic resonance imaging (MRI) has become increasingly important in clinical diagnosis. However, the low...

    Suélio M. Queiroz, Thaís S. Veriato, ... Maiara L. Castilho in Radiological Physics and Technology
    Article 22 November 2023
  18. Safety considerations related to intravenous contrast agents in pediatric imaging

    Intravenous contrast media are used in MRI, CT and US studies for anatomical evaluation and lesion characterization. Safety is always of paramount...

    Safia H. E. Cheeney, Ezekiel Maloney, Ramesh S. Iyer in Pediatric Radiology
    Article 09 August 2022
  19. Evaluation of hafnium oxide nanoparticles imaging characteristics as a contrast agent in X-ray computed tomography

    This research aimed to compare the quantitative imaging attributes of synthesized hafnium oxide nanoparticles (NPs) derived from UiO-66-NH2(Hf) and...

    Arash Safari, Maziyar Mahdavi, ... Masoud Haghani in Radiological Physics and Technology
    Article 17 April 2024
  20. Reducing contrast agent residuals in hospital wastewater: the GREENWATER study protocol

    The potential enviromental impact of iodinated (ICAs) and gadolinium-based contrast agents (GBCAs) have recently come under scrutiny, considering the...

    Moreno Zanardo, Andrea Cozzi, ... Francesco Sardanelli in European Radiology Experimental
    Article Open access 04 May 2023
Did you find what you were looking for? Share feedback.